About Step Pharma
Step Pharma is discovering and developing novel therapeutics that inhibit the enzyme CTP Synthase 1 (CTPS1).
Step Pharma was created on the basis of research on genetic immunodeficiencies led by Prof. Alain Fischer at the Imagine Institute (Paris, France) which established the essential role of CTPS1 in T- and B-cell proliferation.
Latest news
Upcoming events
Step Pharma will be present at the following events
Share this page
Step Pharma
Forum 2
218 avenue Marie Curie
74160 Archamps
France